Seattle Genetics, Astellas drug rapidly shrinks tumors in bladder cancer study
An experimental drug developed by Seattle Genetics Inc and Astellas Pharma Inc led to significant, rapid tumor shrinkage in patients with advanced bladder cancer who had been previously treated with immunotherapy and chemotherapy in a midstage trial, according to data presented on Monday.
from Reuters: Health News https://reut.rs/2WGyLjk
http://bit.ly/2zwRqiM